For clients who've plateaued on tirzepatide or semaglutide, one of the most evidence-dependent future stage in 2026 is optimizing the current protocol. Adjusting dose timing, revisiting macronutrient distribution, or incorporating resistance education to maintain lean mass all through ongoing weight